You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 264 No. 4, July 25, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Nonsteroidal anti-inflammatory drug-associated azotemia in the very old

J. H. Gurwitz, J. Avorn, D. Ross-Degnan and L. A. Lipsitz
Program for the Analysis of Clinical Strategies, Beth Israel Hospital and Harvard Medical School, Boston, Mass.

We conducted a prospective study in 114 elderly patients to determine the renal effects of short-term therapy with nonsteroidal anti-inflammatory drugs (NSAIDs) in the very old. Study subjects were patients in a long-term care facility (mean age, 87 years) newly begun on a regimen of NSAID therapy. For the study group as a whole, the serum urea nitrogen level rose 1.7 mmol/L 5 to 7 days after initiation of therapy, with no significant changes in serum creatinine or potassium levels. In a comparison group of 45 patients not receiving NSAID therapy, no significant change in the serum urea nitrogen level was noted during a similar period. A subgroup of 15 patients (13%) experienced a greater than 50% increase in the serum urea nitrogen level during NSAID therapy, with a mean increase of 89% (8.6 mmol/L). A return to the baseline level occurred within 14 days after discontinuation of NSAID therapy. Two factors were significantly predictors of a greater than 50% increase in the serum urea nitrogen level: concurrent loop diuretic therapy (odds ratio, 2.2) and high NSAID dose (odds ratio, 2.0). These findings suggest that reversible azotemia develops in a sizable proportion of the very old who are treated with short-term NSAID therapy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management of children with Guillain-Barre syndrome
Agrawal et al.
EDUCATION AND PRACTICE 2007;92:161-168.
FULL TEXT  

Adjusting Effect Estimates for Unmeasured Confounding with Validation Data using Propensity Score Calibration
Sturmer et al.
Am J Epidemiol 2005;162:279-289.
ABSTRACT | FULL TEXT  

Analytic Strategies to Adjust Confounding using Exposure Propensity Scores and Disease Risk Scores: Nonsteroidal Antiinflammatory Drugs and Short-term Mortality in the Elderly
Sturmer et al.
Am J Epidemiol 2005;161:891-898.
ABSTRACT | FULL TEXT  

Pharmacotherapy of Congestive Heart Failure in Elderly Patients
Burger and Rocca
J CARDIOVASC PHARMACOL THER 2005;10:85-94.
ABSTRACT  

Quality Indicators for Pain Management in Vulnerable Elders
Chodosh et al.
ANN INTERN MED 2001;135:731-735.
FULL TEXT  

Treatment-related acute renal failure in the elderly: a hospital-based prospective study
Kohli et al.
Nephrol Dial Transplant 2000;15:212-217.
ABSTRACT | FULL TEXT  

Analgesic Nephropathy
De Broe and Elseviers
NEJM 1998;338:446-452.
FULL TEXT  

RISK FACTORS FOR AZOTEMIA FROM NSAIDS IN THE ELDERLY
JWatch General 1990;1990:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.